ストックスクリーナーアプリを入手
8.77
2.45%
0.21
前日終値:
$8.56
開ける：
$8.63
24時間の取引高:
1.23M
Relative Volume:
0.80
時価総額：
$472.09M
収益：
$217.25M
当期純損益:
$-50.92M
株価収益率:
-8.77
EPS:
-1
ネットキャッシュフロー:
$-100.85M
1週間 パフォーマンス:
+6.30%
1か月 パフォーマンス:
+34.30%
6か月 パフォーマンス:
-43.64%
1年 パフォーマンス:
-58.73%
1日の値動き範囲:
$8.52
$8.97
1週間の範囲:
$8.28
$8.97
52週間の値動き範囲:
$4.32
$22.83
Prothena Corporation Plc Stock (PRTA) Company Profile
名前
Prothena Corporation Plc
セクター
電話
011-353-1-236-2500
住所
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
PRTA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
8.77 | 459.17M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-28 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2025-05-27 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | ダウングレード | Jefferies | Buy → Hold |
| 2025-05-27 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-12-20 | 開始されました | Chardan Capital Markets | Buy |
| 2024-01-30 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2023-04-24 | 開始されました | SVB Securities | Outperform |
| 2023-01-27 | 開始されました | Piper Sandler | Overweight |
| 2022-11-04 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-11-19 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-06-18 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-06-08 | 繰り返されました | Oppenheimer | Outperform |
| 2021-05-26 | 開始されました | Citigroup | Buy |
| 2021-02-26 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | アップグレード | Jefferies | Hold → Buy |
| 2021-02-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-12-07 | 開始されました | H.C. Wainwright | Buy |
| 2020-07-09 | アップグレード | Oppenheimer | Perform → Outperform |
| 2019-11-19 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-05-21 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2018-04-23 | ダウングレード | Jefferies | Buy → Hold |
| 2018-04-05 | 繰り返されました | Barclays | Overweight |
| 2017-11-20 | ダウングレード | Wedbush | Outperform → Neutral |
| 2017-09-29 | 繰り返されました | BTIG Research | Buy |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-11 | 開始されました | Jefferies | Buy |
| 2017-04-12 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-04-12 | 開始されました | Piper Jaffray | Overweight |
| 2017-03-02 | 開始されました | Instinet | Buy |
| 2016-12-21 | 開始されました | SunTrust | Buy |
| 2016-11-03 | 開始されました | Deutsche Bank | Buy |
| 2016-08-04 | 繰り返されました | Barclays | Overweight |
| 2016-05-13 | 開始されました | Barclays | Overweight |
| 2016-02-19 | 繰り返されました | Wedbush | Outperform |
| 2016-01-21 | 開始されました | Credit Suisse | Outperform |
すべてを表示
Prothena Corporation Plc (PRTA) 最新ニュース
Prothena Corporation plc stock outlook for YEARPortfolio Profit Report & High Win Rate Trade Alerts - Newser
Strategies to average down on Prothena Corporation plcJuly 2025 Update & Short-Term High Return Ideas - Newser
Is Prothena Corporation plc still worth holding after the dipWeekly Trend Report & Intraday High Probability Setup Alerts - Newser
How institutional ownership impacts Prothena Corporation plc stockWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Can swing trading help recover from Prothena Corporation plc lossesWeekly Stock Recap & Consistent Growth Equity Picks - Newser
Tick level data insight on Prothena Corporation plc volatilityBuy Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Using data models to predict Prothena Corporation plc stock movement2025 Volume Leaders & AI Driven Stock Movement Reports - Newser
Earnings visualization tools for Prothena Corporation plcQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser
Is Prothena Corporation plc trending in predictive chart modelsMarket Risk Analysis & Short-Term High Return Ideas - Newser
Relative strength of Prothena Corporation plc in sector analysisJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Ranking Prothena Corporation plc among high performing stocks via tools2025 Technical Overview & Stock Portfolio Risk Management - Newser
Will a bounce in Prothena Corporation plc offer an exitPortfolio Update Summary & Target Return Focused Stock Picks - Newser
Key resistance and support levels for Prothena Corporation plcPrice Action & Expert Curated Trade Ideas - Newser
Will Prothena Corporation plc see short term momentum2025 Trading Recap & Growth Focused Entry Reports - Newser
Recovery Signals Appearing in Prothena Corporation plc Charts2025 Macro Impact & High Conviction Buy Zone Picks - beatles.ru
Is Prothena Corporation plc Forming a Consolidation Base2025 Historical Comparison & Accurate Buy Signal Alerts - beatles.ru
Prothena Corporation plc Stocks Attracting Dip Buyers2025 Support & Resistance & Accurate Intraday Trade Tips - newsyoung.net
Published on: 2025-08-14 23:29:29 - sundaytimes.kr
Prothena’s SWOT analysis: stock outlook shifts amid pipeline changes By Investing.com - Investing.com Canada
Prothena’s SWOT analysis: stock outlook shifts amid pipeline changes - Investing.com
Can trapped investors hope for a rebound in Prothena Corporation plcFree Investment Strategy With Low Risk - Newser
What MACD signals say about Prothena Corporation plcForecast Model for Intraday Buy Signals - Newser
How to escape a deep drawdown in Prothena Corporation plcFree Low Risk High Return Opportunities - Newser
How to build a dashboard for Prothena Corporation plc stockSummary of Reliable Long-Term Trade Models - Newser
Building trade automation scripts for Prothena Corporation plcBreakout Stock Opportunities with Low Drawdown - Newser
Volume spikes in Prothena Corporation plc stock – what they meanFree Safe Entry Stock Watch Suggestions - Newser
How Prothena Corporation plc stock performs during market volatilityLow Exposure Strategy with Sector Analysis - Newser
Trend Reversal Possible in Prothena Corporation plc Charts IndicateSmart Allocation Stock Pick Insights Gaining Interest - metal.it
Royal Bank Of Canada Cuts Prothena (NASDAQ:PRTA) Price Target to $10.00 - Defense World
Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy - BioSpace
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful - Investing.com India
Prothena (PRTA) Surges on Novo Nordisk's Phase 3 Plans for ATTR Amyloidosis Drug - GuruFocus
Prothena’s Coramitug Advances to Phase 3 with Novo Nordisk - TipRanks
Prothena Announces that Novo Nordisk Will Advance Coramitug (For - GuruFocus
Breakthrough: Novo Nordisk Takes Prothena's ATTR Drug to Final Trial Stage with $1.2B Milestone Potential - Stock Titan
Applying sector rotation models to Prothena Corporation plcFree Swing Trading Entry Point Signals - Newser
Prothena announces that Novo Nordisk will advance Coramitug into phase 3 development - MarketScreener
Prothena stock price target lowered to $10 at RBC on program discontinuation By Investing.com - Investing.com South Africa
Prothena stock price target lowered to $10 at RBC on program discontinuation - Investing.com Nigeria
PRTA: RBC Capital Maintains Rating, Lowers Price Target | PRTA S - GuruFocus
9 Analysts Assess Prothena Corp: What You Need To Know - 富途牛牛
Prothena’s Losses Grow As Revenue Drops And Programs Wind Down - Finimize
RBC Cuts Price Target on Prothena to $10 From $18, Keeps Sector Perform, Speculative Risk - MarketScreener
Prothena Corp (PRTA) Maintains 'Buy' Rating with $18 Target by C - GuruFocus
JMP reiterates Market Outperform rating on Prothena stock ahead of key data - Investing.com Nigeria
Prothena Reports Second Quarter 2025 Financial Results and Business Highlights - BioSpace
Prothena Reports Q2 2025 Financial Results and Pipeline Progress - TipRanks
Prothena Corporation Plc (PRTA) 財務データ
収益
当期純利益
現金流量
EPS
Prothena Corporation Plc (PRTA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
| EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
| SCULLY WILLIAM P | 10% Owner |
Jan 14 '25 |
Buy |
12.79 |
100,000 |
1,279,040 |
735,993 |
| SCULLY WILLIAM P | 10% Owner |
Dec 18 '24 |
Buy |
13.93 |
73,436 |
1,022,670 |
1,297,693 |
| SCULLY WILLIAM P | 10% Owner |
Dec 31 '24 |
Buy |
13.01 |
32,000 |
416,393 |
650,193 |
| SCULLY WILLIAM P | 10% Owner |
Dec 20 '24 |
Buy |
15.91 |
2,000 |
31,813 |
618,693 |
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):